Upregulated Expression of CYBRD1 Predicts Poor Prognosis of Patients with Ovarian Cancer

Table 5

Characteristics of patients with OV obtained in EH cohort.

Characteristic	Low expression of CYBRD1	High expression of CYBRD1
N	34	66
OS event			<0.001
Alive	28 (28%)	23 (23%)
Dead	6 (6%)	43 (43%)
Survival times, years			<0.001
<1	0 (0.0)	9 (9%)
1–3	4 (4%)	27 (27%)
3–5	9 (9%)	17 (17%)
≥5	21 (21%)	13 (13%)
FIGO stage, n (%)			0.014
Stage I	19 (19%)	23 (23%)
Stage II	5 (5%)	3 (3%)
Stage III	8 (8%)	35 (35%)
Stage IV	2 (2%)	5 (5%)
Lymphatic invasion, n (%)			0.017
No	25 (25%)	32 (32%)
Yes	9 (9%)	34 (34%)
Histologic grade, n (%)			<0.001
G1 + G2	20 (20%)	11 (11%)
G3 + G4	14 (14%)	55 (55%)
Age, n (%)			0.404
≤60	23 (23%)	39 (39%)
>60	11 (11%)	27 (27%)